Study #RTOG1304
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axilla
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effective than standard radiation therapy in treating patients with breast cancer
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Stage IB Breast Cancer;Stage II Breast Cancer
Study phase:
Not applicable
Physician name:
Simona Shaitelman
Department:
Radiation Oncology
For general questions about clinical trials:
1-855-614-1563
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.